Research Surgical outcomes of hepatocellular carcinoma patients with Child-Pugh grade B liver function and beyond Milan criteria

Author:

Lu Zhan1,Li Jindu1,Gao Junping2,Xie Yilin2,Gong Wenfeng1,Xiang Bangde1

Affiliation:

1. Guangxi Medical University Cancer Hospital

2. Guangxi Medical University

Abstract

Abstract Background Due to impaired liver function, hepatocellular carcinoma (HCC) patients with Child-Pugh grade B (CPG-B) liver function need carefully chosen treatment. Radical treatment for patients beyond Milan criteria is limited. It has not been established whether hepatectomy is safe and effective under these circumstances. Methods This was a retrospective analysis of patients from January 2010 to October 2021 in a tertiary care centre. Postoperative complications and oncological prognosis were observed. Then, we investigated the feasibility of major hepatectomy for HCC in patients with CPG-B liver function. Results Among HCC patients with CPG-B liver function, recurrence-free survival (RFS) and overall survival (OS) significantly differed between patients with Milan criteria and those beyond Milan criteria (p < 0.05), but there was no significant difference in 90-day mortality (4.8% vs. 4.4%) or postoperative complications (55.4% vs. 57.0%). The 1-, 3-, and 5-year RFS for patients beyond Milan criteria were 42.2%, 22.8%, and 15.1%, respectively, while the 1-, 3-, and 5-year OS were 76.6%, 48.1%, and 36.0%, respectively. In HCC patients beyond Milan criteria, an inverse probability treatment weighting (IPTW) analysis revealed significant differences in RFS and OS between minor hepatectomy and major hepatectomy (p < 0.05). Cox proportional analysis also revealed that major hepatectomy was a prognostic factor for worse RFS (hazard ratio (HR): 1.77, 95% confidence interval (CI): 1.14–2.73) and OS (HR: 1.57, 95% CI: 1.01–2.82). Conclusion Hepatectomy is still feasible in HCC patients with CPG-B liver function and beyond Milan criteria, but major hepatectomy will result in a poor prognosis.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3